Tegaserod maleate

CAS No. 189188-57-6

Tegaserod maleate ( SDZ-HTF 919; Zelnorm )

Catalog No. M12965 CAS No. 189188-57-6

Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 65 In Stock
50MG 110 In Stock
100MG 188 In Stock
200MG 285 In Stock
500MG 482 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tegaserod maleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation.
  • Description
    Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome.
  • Synonyms
    SDZ-HTF 919; Zelnorm
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT; Sert (Sodium-dependent)
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    189188-57-6
  • Formula Weight
    417.46
  • Molecular Formula
    C20H27N5O5
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 35mg/mL
  • SMILES
    CCCCCN=C(N)NN/C=C/1\C=NC2=C1C=C(C=C2)OC.C(=C\C(=O)O)\C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Beattie DT, et al. Br J Pharmacol. 2004 Nov;143(5):549-60.
molnova catalog
related products
  • Histamine

    Histamine is an organic nitrogenous compound involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.

  • Nafronyl oxalate

    A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.

  • SB-357134

    A potent, selective, orally active and CNS penetrant 5-HT6 receptor antagonist with pKi of 8.5.